Co-located with BioJapan

Sponsors' Microsites

Press Releases


Novosanis attending Life Sciences week and BioJapan


A 2016 Nobel Prize for Dr. Yoshinori Ohsumi is an even bigger win for the world.


Introduction to the National Center Biobank Network


NanoCarrier: Results of a Phase Ib Clinical Study of NC-6004 in the US


Licensing out: treatment of ADHD (Attention Deficit Disorder and Hyperactivity Disorder)


Human recombinant Tissue Factor-based hemostat


In vitro 3D culture platform for drug developments and regenerative medicine


Contactless Mastication Detector and Eye-Blink Analyzer


Vorpal Technologies delivers End-to-End Solutions for Success in Japan’s Healthcare Market


RX sterile single dose vials (Blow-Fill-Seal), with FDA approval


INCJ and 10 portfolio companies in the health and medical field to jointly exhibit at BioJapan 2016


Latest advanced research activities and achievements in Okayama University


Computational drug discovery using Big Data and machine learning.


Presentation Program at AIST Booth (A-40)


International service provider, looking for partners who are interested in education business development.


Drug Discovery Through Zebrafish, outsourcing innovative solutions for your novel molecule screenings


Pharma's partner of choice for discovery services


Tokyo Future Style opens a new global office in Taipei


Webinar Series: Regulations and approval process for veterinary drugs in different regions of the world


3D cell culture plate <Elplasia> - You can get hundreds of spheroids in one well with uniformed size, easily.


Novel bio-adhesive hemostatics, "PyteQ", was developed, and now available. Animal clinical studies are ongoing with Exosomes- and DNA-Vaccines against tumors. Looking for Partners for Production, Sale & Joint Development


We support your pharmacology. May we help with your monkey studies?



Asia's Premier Partnering Event for the Global Biotechnology Industry

BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities. The Japanese and global biotechnology industry's top business development and licensing professionals, alliance management professionals, R&D personnel and biotech company executives will gather in Yokohama for the 18th BioJapan.





Name BioJapan 2016
Date & Time October 12th wed. – 14th fri., 2016 10:00-17:00 (8:45- Partnering)
VenuePacifico Yokohama, Japan
Special Supported by City of Yokohama
Special Cooperated by Kanagawa Prefecture, City of Kawasaki
Exhibition registration JPY5,000 (Free admission with advanced registration)
Partnering registration
  • Regular fee
    JPY60,000 (incl. tax) per 1 registration
  • Organizing associations' member
    JPY50,000 (incl. tax) per 1 registration

BioJapan Organizing Committee

  • Chairman Sakayu Shimizu
    Chairman of Japan Bioindustry Association
    (Professor Emeritus, Kyoto University)
  • Deputy Chairman Toichi Takenaka
    Chairman of Japan Health Sciences Foundation
    (Former Chairman of Astellas Pharma Inc.)
  • Deputy Chairman Koichiro Aramaki
    President of Japan Association for Techno-innovation in Agriculture, Forestry and Fisheries
    (Former Chairman of Kirin Holdings Company Ltd.)
  • Deputy Chairman Kiyoshi Miwa
    Chairman of Japan Biological Informatics Consortium
    (Visiting Fellow of Ajinomoto Co., Inc.)
  • Deputy Chairman Koichiro Aramaki
    Chairman of Japan Association of Bioindustries Executives
    (Former Chairman of Kirin Holdings Company Ltd.)
  • Deputy Chairman Yoshihiko Hatanaka
    President of Japan Pharmaceutical Manufacturers Association
    (President and CEO of Astellas Pharma Inc.)
  • Deputy Chairman Takaharu Tanaka
    Chairman of NPO Kinki Bio-industry Development Organization
    (President, Hoshi University)
  • Deputy Chairman Yoichi Kaya
    President of Research Institute of Innovative Technology for the Earth
    (Professor Emeritus, The University of Tokyo)
  • Deputy Chairman Yuzo Toda
    Chairman of Forum for Innovative Regenerative Medicine
    (Director Senior Executive Vice President CTO FUJIFILM Corporation)
  • President Osamu Nagayama
    President of Japan Bioindustry Association
    (Chairman of the Board of Directors, Chairman and CEO of Chugai Pharmaceutical)

JTB Communication Design, Inc.

Supported by
Cabinet Office / Ministry of Education, Culture, Sports, Science and Technology / Ministry of Health, Labour and Welfare / Ministry of Agriculture, Forestry and Fisheries of Japan / Ministry of Economy, Trade and Industry / Hokkaido Bioindustry Association / Japan Agency for Medical Research and Development / Japan Analytical Instruments Manufacturers' Association / Japan Association for Chemical Innovation / Japan Association of Medical Devices Industries / Japan BioPlastics Association / Japan External Trade Organization / Japan Science and Technology Agency / Japan Scientific Instruments Association / Kazusa DNA Research Institute / Kihara Memorial Yokohama Foundation for the Advancement of Life Sciences / National Agriculture and Food Research Organization / National Institute of Advanced Industrial Science and Technology / National Institute of Technology and Evaluation / New Energy and Industrial Technology Development Organization / Organization for Small & Medium Enterprises and Regional Innovation, JAPAN / RIKEN / British Embassy Tokyo, UK Trade & Investment Dept. / Commercial and Investment Office, Business Sweden, Embassy of Sweden / Embassy of Canada to Japan / Embassy of Switzerland in Japan / Embassy of the Federal Republic of Germany / Embassy of the Kingdom of Belgium / Embassy of the Kingdom of the Netherlands / Finland Trade Center, Embassy of Finland / French Embassy - Business France / U.S. Department of Commerce (U.S. Embassy – Foreign Commercial Service)


Copyright© 2016 JTB Communication Design, Inc. All rights reserved.